Potential witnesses against Martin Shkreli fear that the former pharma executive will retaliate if they testify in a criminal fraud case, federal prosecutors said.
Shkreli, the biotechnology company founder best known for raising a rare drug’s price by more than 5,000 percent, has a pattern of threatening or intimidating those who come into conflict with him, worrying potential witnesses in his criminal case, the prosecutors said in a court filing Thursday in Brooklyn, New York, federal court.
The government has a “well-founded concern of witness intimidation based on defendant Shkreli’s past behavior,” they told U.S. District Judge Kiyo Matsumoto.
